BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 32839113)

  • 1. Risk factors affecting the failure to complete treatment for patients with latent tuberculosis infection in Tokyo, Japan.
    Sugishita Y; Goto C; Sakamoto T; Sugawara T; Ohkusa Y
    J Infect Chemother; 2020 Nov; 26(11):1129-1133. PubMed ID: 32839113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trend and treatment outcomes of latent tuberculosis infection among migrant persons in Japan: retrospective analysis of Japan tuberculosis surveillance data.
    Kawatsu L; Uchimura K; Ohkado A
    BMC Infect Dis; 2021 Jan; 21(1):42. PubMed ID: 33422003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A situational analysis of latent tuberculosis infection among incarcerated population in Japan.
    Kawatsu L; Uchimura K; Ohkado A
    PLoS One; 2018; 13(9):e0203815. PubMed ID: 30192897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of latent tuberculosis infection in Japan-born and foreign-born children in Japan.
    Kasuya S; Imai A; Uchimura K; Ohkado A; Kawatsu L
    Western Pac Surveill Response J; 2023; 14(4):1-7. PubMed ID: 38230255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trend and treatment status of latent tuberculosis infection patients in Japan - Analysis of Japan TB Surveillance data.
    Kawatsu L; Uchimura K; Ohkado A
    PLoS One; 2017; 12(11):e0186588. PubMed ID: 29091917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment completion for latent tuberculosis infection in Norway: a prospective cohort study.
    Schein YL; Madebo T; Andersen HE; Arnesen TM; Dyrhol-Riise AM; Tveiten H; White RA; Winje BA
    BMC Infect Dis; 2018 Nov; 18(1):587. PubMed ID: 30453946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment guidelines for latent tuberculosis infection.
    ;
    Kekkaku; 2014 Jan; 89(1):21-37. PubMed ID: 24654427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence to nine-month isoniazid for latent tuberculosis infection in healthcare workers: a prospective study in a tertiary hospital.
    Chung SJ; Lee H; Koo GW; Min JH; Yeo Y; Park DW; Park TS; Moon JY; Kim SH; Kim TH; Sohn JW; Yoon HJ
    Sci Rep; 2020 Apr; 10(1):6462. PubMed ID: 32296096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Completion rate of latent tuberculosis infection treatment in patients aged 65 years and older.
    Noh CS; Kim HI; Choi H; Kim Y; Kim CH; Choi JH; Hyun IG; Baek MS
    Respir Med; 2019 Oct; 157():52-58. PubMed ID: 31522030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating Latent Tuberculosis Infection Using Interferon-γ Release Assay, Japan.
    Nishimura T; Ota M; Mori M; Hasegawa N; Kawabe H; Kato S
    Emerg Infect Dis; 2018 Nov; 24(11):2111-2113. PubMed ID: 30334726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Completion of treatment for latent tuberculosis infection with monthly drug dispensation directly through the tuberculosis clinic.
    Dobler CC; Marks GB
    PLoS One; 2012; 7(11):e48900. PubMed ID: 23139824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment and management of latent tuberculosis infection in a refugee population in the Northern Territory.
    Trauer JM; Krause VL
    Med J Aust; 2011 Jun; 194(11):579-82. PubMed ID: 21644870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Better Completion of Pediatric Latent Tuberculosis Treatment Using 4 Months of Rifampin in a US-based Tuberculosis Clinic.
    Gaensbauer J; Aiona K; Haas M; Reves R; Young J; Belknap R
    Pediatr Infect Dis J; 2018 Mar; 37(3):224-228. PubMed ID: 28777204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initiation and completion of treatment for latent tuberculosis infection in migrants globally: a systematic review and meta-analysis.
    Rustage K; Lobe J; Hayward SE; Kristensen KL; Margineanu I; Stienstra Y; Goletti D; Zenner D; Noori T; Pareek M; Greenaway C; Friedland JS; Nellums LB; Hargreaves S;
    Lancet Infect Dis; 2021 Dec; 21(12):1701-1712. PubMed ID: 34363771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of Latent Tuberculosis Infection Among Healthcare Workers: 10-Year Experience at a Single Center.
    Arguello Perez E; Seo SK; Schneider WJ; Eisenstein C; Brown AE
    Clin Infect Dis; 2017 Nov; 65(12):2105-2111. PubMed ID: 29020308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuberculosis despite latent infection screening and treatment in patients receiving TNF inhibitor therapy.
    Kaptan Y; Suner A; Taş MN; Oksel F; Aksu K; Sayiner A
    Clin Rheumatol; 2021 Sep; 40(9):3783-3788. PubMed ID: 33745083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The latent tuberculosis cascade-of-care among people living with HIV: A systematic review and meta-analysis.
    Bastos ML; Melnychuk L; Campbell JR; Oxlade O; Menzies D
    PLoS Med; 2021 Sep; 18(9):e1003703. PubMed ID: 34492003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of latent TB Infection and the risk of tuberculosis after solid organ transplantation: Comprehensive review.
    Abad CLR; Deziel PJ; Razonable RR
    Transpl Infect Dis; 2019 Dec; 21(6):e13178. PubMed ID: 31541575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance to First-Line Antituberculosis Drugs in Washington State by Region of Birth and Implications for Latent Tuberculosis Treatment Among Foreign-Born Individuals.
    Furukawa NW; Haider MZ; Allen SJ; Carlson SL; Lindquist SW
    Am J Trop Med Hyg; 2017 Mar; 96(3):543-549. PubMed ID: 27994106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Programmatic Effectiveness of Latent Tuberculosis Care Cascade in a Community Health Center.
    Prater C; Holzman S; Shah M
    J Immigr Minor Health; 2021 Jun; 23(3):566-573. PubMed ID: 32705451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.